SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-271440
Filing Date
2021-09-13
Accepted
2021-09-13 16:14:02
Documents
3
Period of Report
2021-09-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d181157d8k.htm 8-K 17752
2 EX-99.1 d181157dex991.htm EX-99.1 68705
3 GRAPHIC g181157g0913214640449.jpg GRAPHIC 2996
  Complete submission text file 0001193125-21-271440.txt   91869
Mailing Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102 (858) 775-4523
Icosavax, Inc. (Filer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40655 | Film No.: 211249827
SIC: 2836 Biological Products, (No Diagnostic Substances)